DESIREE LITTLE: Open Payments
NPI 1326678319 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,055 in 76 payments from 21 companies in 2025. Trend: 2023 $2,171 · 2024 $1,998 · 2025 $2,055
Food & beverage: $2,055
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $634 |
| Amgen Inc. | 11 | $262 |
| Becton, Dickinson and Company | 1 | $172 |
| Novartis Pharmaceuticals Corporation | 7 | $148 |
| PFIZER INC. | 6 | $132 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $96 |
| Lilly USA, LLC | 4 | $85 |
| Regeneron Healthcare Solutions, Inc. | 2 | $72 |
| Philips North America LLC | 2 | $55 |
Products named: Wegovy, REPATHA, LEQVIO, Kerendia, VYNDAQEL, JARDIANCE, EVKEEZA, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
